A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease

NCT02221362 · clinicaltrials.gov ↗

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Late-onset Pompe Patients Untreated or Treated With rhGAA

Sponsor

BioMarin Pharmaceutical